With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

Aperio Technologies, Inc. has launched TMALab II, the latest release of the company’s web-based digital pathology information management system, built specifically for researchers who use Tissue ...

Planned for release in early Q2 2010, i-Path has developed a TMA solution which will provide Researchers with a web-based system for scoring TMAs for faster biomarker discovery. The toolbox will ...

Despite the early promise of easily staining and analyzing hundreds of tumors, several problems remain with respect to the use of TMAs, such as bottlenecks in relation to the grading/evaluation stage ...

Accurate classification of tissue samples is an essential tool in disease diagnosis and treatment. The DNA microarray technology enables disease classification based only on gene expression analysis, ...